Symbiosis Pharmaceutical Services Ltd, is a world-class contract manufacturing organisation (CMO) that specialises in the GMP manufacture and sterile fill/finish of vials for clinical trials and low volume commercial supply.

Providing analytical testing, clinical labelling and packaging, Qualified Person release, controlled temperature storage and project management services, the CMO has core capabilities in lyophilization and handling capabilities for cytotoxic drugs with a unique infrastructure built around its facility, industry expertise, and product process.

Having purpose-built its 7000-sq.ft. MHRA-licensed facility at the Innovation Park in Stirling, Scotland in 2011, its unique design offers fast access to manufacturing slots, so clinical and commercial batches can progress to batch release in less time.

Regulatory compliance, technical capability and operational flexibility are core to Symbiosis’ offerings and direct access to the best people who deliver client projects on time.

Types of molecules handled:
Biologics
Proteins
Peptides
DNA
Antibody-Drug Conjugates (ADCs)
Cytotoxic, cytostatic and highly potent APIs